Efficient GPCR Drug Discovery by combining Novel Cell-Based Kinetic Assays with Systems Biology

Core team


My Image

Dr. Martin Ostermaier

Biochemist, inventor, ETH pioneer fellow

My Image

Dr. Maria Waldhoer

Twenty years track record in GPCR signalling with extensive experience in academia & industry

My Image

Dr. Aurélien Rizk

Computer scientist (ENS Rennes, France), systems biologist

My Image

Mr. Luca Zenone

MSc ETH BA (MTEC), engineer, management consultant

Scientific and Business Advisors


My Image

Prof. Gebhard Schertler – Head of Biology & Chemistry at the Paul Scherrer Institute, Prof. of Structural Biology at ETH Zürich, Entrepreneur, Co-Founder and Head of Scientific Advisory Board

Prof. Michel Bouvier – Chief Executive Officer of the Institute for Research in Immunology and Cancer (IRIC) and professor in the Department of Biochemistry and Molecular Medicine at the Faculty of Medicine of the University of Montreal.

Dr. Chris de Graaf – Director Computational Chemistry - Heptares Therapeutics

My Image

Prof. Jennifer L. Whistler - Associate Director, Center for Neuroscience, Professor of Physiology and Membrane Biology, University of California, Davis.

My Image

Prof. Claudio Costa-Neto – Associate Prof. of Biochemistry at University of Sao Paulo, Consultant at Sofinnova Partners.

My Image

Dr. Philipp Berger – Cell Biologist, PSI Project Leader, Co-Founder.

My Image

Dr. Werner Enz – CTI Coach, CEO of Basel Inkubator and EVA, the life sciences start-up agency.

Directory Board



  • Dr. Martin Ostermaier

  • Luca Zenone

  • Dr. Yiannis Monovoukas

  • Theo Melas-Kyriazi

  • Prof. Dr. Jens Gobrecht